The impact of injecting networks on hepatitis C transmission and treatment in people who inject drugsMargaret Hellard, Emma S. McBryde, David A. Rolls et al.|Hepatology|2014Cited by 134
Eradication of Hepatitis C Infection: The Importance of Targeting People Who Inject DrugsMargaret Hellard, Emma S. McBryde, Joseph Doyle et al.|Hepatology|2013Cited by 84
Meropenem versus piperacillin-tazobactam for definitive treatment of bloodstream infections due to ceftriaxone non-susceptible Escherichia coli and Klebsiella spp (the MERINO trial): study protocol for a randomised controlled trialPatrick N. A. Harris, David L. Paterson, Jonathan R. Iredell et al.|Trials|2015Cited by 73
Hepatitis C Transmission and Treatment in Contact Networks of People Who Inject DrugsDavid A. Rolls, Margaret Hellard, Rachel Sacks‐Davis et al.|PLoS ONE|2013Cited by 72
Hepatitis C transmission and treatment as prevention – The role of the injecting networkMargaret Hellard, Garry Robins, Emma S. McBryde et al.|International Journal of Drug Policy|2015Cited by 65